Yao Wang Yimeng Wang Jinming Yu Xiangjiao Meng
10.3389/fimmu.2022.998516
Front Immunol
2022 Sep 15;13:998516.
cancer immunotherapy immune checkpoint inhibitors (ici) immune-related adverse event(irae) pneumonitis programmed cell death 1 inhibitor
CC BY
https://pubmed.ncbi.nlm.nih.gov/36189237/
Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell Lung Neoplasms Pneumonia / chemically induced Pneumonia / drug therapy
Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell Lung Neoplasms Pneumonia / chemically induced Pneumonia / drug therapy Case Reports Research Support, Non-U.S. Gov't B7-H1 Antigen Epithelial Cells Humans Immune Checkpoint Inhibitors / adverse effects Ligands Lung Programmed Cell Death 1 Receptor B7-H1 Antigen Immune Checkpoint Inhibitors Ligands Programmed Cell Death 1 Receptor
PMC9520566
36189237
Case report: Pneumonia with clinical symptoms precedes imaging evidence after immune checkpoint inhibitors combined with radiotherapy in lung squamous cell cancer
2022